Rapid Communication| Volume 6, ISSUE 4, P178-179, April 1997

Download started.


Aspirin, ticlopidine, and warfarin: When and why

  • David G. Sherman
    Address reprint requests to David G. Sherman, MD, Department of Neurology, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr, San Antonio, TX 78284-7883.
    Division of Neurology, Department of Medicine, University of Texas Health Science Center at San Antonio, San antonio, TX., USA
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Antiplatelet Trialists' Collaboration
        Collaborative overview of randomized trials of antiplatelet therapy: 1. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients.
        BMJ. 1995; 308: 81-106
        • Sherman DG
        • Dyken ML
        • Gent M
        • et al.
        Antithrombotic therapy for cerebrovascular disorders: an update.
        Chest. 1995; IV108: 444S-456S
        • Dutch TIA Trial Group
        A comparison of two doses of aspirin (30 mg vs. 233 mg a day) in patients after a transient ischemic attack of minor ischemic stroke.
        N Engl J of Med. 1991; 325: 1261-1266
        • The Steering Committee of the Physicians' Health Study Research Group
        Final report on the aspirin component of the ongoing Physicians' Health Study.
        N Engl J Med. 1989; 321: 129-135
        • Hass WK
        • Easton JD
        • Adams HP
        • et al.
        A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients.
        N Engl J Med. 1989; 321: 501-507
        • Gent M
        • Blakely JA
        • Easton JD
        • et al.
        The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke.
        Lancet. 1989; 1: 1215-1220
        • CAPRIE Steering Committee
        A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE).
        Lancet. 1996; : 1329-1339